Influence of severity of anemia on clinical findings in infants with sickle cell anemia: Analyses from the BABY HUG study

Jeffrey D. Lebensburger, Scott T. Miller, Thomas H. Howard, James F. Casella, R. Clark Brown, Ming Lu, Rathi V. Iyer, Sharada Sarnaik, Zora R. Rogers, Winfred C. Wang

Research output: Contribution to journalArticle

Abstract

Background: Clinical complications of sickle cell anemia begin in infancy. BABY HUG (ClinicalTrials.gov, NCT00006400) was a NHLBI-NICHD supported randomized phase III placebo-controlled trial of hydroxyurea (HU) in infants (recruited at 9-18 months) unselected for clinical severity with sickle cell anemia. This secondary analysis of data from BABY HUG examines the influence of anemia on the incidence of sickle cell related complications, and the impact of hydroxyurea therapy in altering these events by comparing children with lower (<25th percentile) and higher (>75th percentile) hemoglobin concentrations at study entry. Procedure: Infants were categorized by: (1) age-adjusted hemoglobin quartiles as determined by higher (Hi) and lower (Lo) hemoglobin concentrations at study entry (9-12 months old: <8.0 and >10.0gm/dL; 12-18 months old: <8.1 and >9.9gm/dL) and (2) treatment arm (hydroxyurea or placebo). Four subgroups were created: placebo (PL) LoHb (n=25), PL HiHb (n=27), hydroxyurea (HU) LoHb (n=21), and HU HiHb (n=18). The primary and secondary endpoints of BABY HUG were analyzed by subgroup. Results: Infants with lower hemoglobin at baseline were more likely to have a higher incidence of clinical events (acute chest syndrome, pain crisis, fever) as well as higher TCD velocities and lower neuropsychological scores at study exit. Hydroxyurea reduced the incidence of these findings. Conclusion: Infants with more severe anemia are at risk for increased clinical events that may be prevented by early initiation of hydroxyurea. Pediatr Blood Cancer 2012;59:675-678.

Original languageEnglish (US)
Pages (from-to)675-678
Number of pages4
JournalPediatric Blood and Cancer
Volume59
Issue number4
DOIs
StatePublished - Oct 1 2012

Keywords

  • Acute chest syndrome
  • Hydroxyurea
  • Pain
  • Renal
  • Sickle cell anemia
  • Spleen
  • Transcranial doppler

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Influence of severity of anemia on clinical findings in infants with sickle cell anemia: Analyses from the BABY HUG study'. Together they form a unique fingerprint.

  • Cite this

    Lebensburger, J. D., Miller, S. T., Howard, T. H., Casella, J. F., Brown, R. C., Lu, M., Iyer, R. V., Sarnaik, S., Rogers, Z. R., & Wang, W. C. (2012). Influence of severity of anemia on clinical findings in infants with sickle cell anemia: Analyses from the BABY HUG study. Pediatric Blood and Cancer, 59(4), 675-678. https://doi.org/10.1002/pbc.24037